SLECT

About this trial

An observational study to screen survivors of testicular cancer for late side effects including recurrence of cancer, second malignant neoplasms, cardiovascular, metabolic, hormonal and respiratory complications.

Patient Profile

Patients who have been discharged from Oncology services after successfully completing treatment and surveillance of testicular cancer

Where’s this trial being run?

Tallaght University Hospital

Can I join this study / trial?

The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.

Why not Print this page and bring it with you. It will help your doctor and research team advise you.

For more detailed information

Questions?

Here’s a list of questions you may have for your doctor or local cancer research team.


Summary Data

Name: SLECT
Number: 23-09
Full Title:

Long-term Sequelae of Testicular Cancer and Treatment

Principal Investigator: Dr Muhammad Raheel Khan
Type: Collaborative
Sponsor:

Tallaght University Hospital

Recruitment Started: Global:
Ireland: April 2023
Global Recruitment Target:
Ireland Recruitment Target: 150